GABA + L-Theanine

by Vera's Formulations · capsule · 60 capsules

  • Off the market since August 2022 (NIH)
  • UPC 9 319091 999409
  • DSLD label 256593
  • Serving 1 capsule
  • 30 servings

GABA + L-Theanine by Vera's Formulations lists 2 ingredients, 2 with an amount per serving of 1 capsule, such as 400 mg of gamma aminobutyric acid and 100 mg of L-theanine. Its current label entered the NIH Dietary Supplement Label Database on August 23, 2021.

What is in GABA + L-Theanine?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

GABA + L-Theanine: Supplement Facts rows against the market (DSLD label 256593, January 2026 release)
IngredientAmount% DVAmong products listing it
Gamma Aminobutyric Acid400 mgGABA in GABA + L-Theanine against 744 products400 mg per serving; the middle half of products list 80 mg to 400 mg, the median 100 mg.400 mg

Higher than 74% of 744 products listing GABA (median 100 mg). Per day at the most servings: 800 mg.

L-Theanine100 mgTheanine in GABA + L-Theanine against 1,602 products100 mg per serving; the middle half of products list 90 mg to 200 mg, the median 100 mg.100 mg

47% of 1,602 products listing theanine give more (median 100 mg). Per day at the most servings: 200 mg.

Source: NIH ODS Dietary Supplement Label Database, label 256593 (entered August 23, 2021), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records 2 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Adult Dose: Take 1 capsule twice daily with food or as recommended by your registered healthcare practitioner.
Warnings
For Practitioner Dispensing Only
Warning: Vitamin and mineral supplements should not replace a balanced diet. If symptoms persist, seek the advice of a healthcare professional. Do not use if tamper evidence seal is broken. Bottle sealed under cap for your protection.
Keep out of reach of children.
Storage
Store below 25 degrees C in a cool, dry place away from direct sunlight.

Source: label statements in DSLD label 256593.

How many labels does GABA + L-Theanine have?

One label is on file, entered on August 23, 2021.

  1. Label 256593 (current) Entered August 23, 2021 · off the market August 31, 2022 · 60 capsules · UPC 9 319091 999409

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Dr Vera's Formulations (manufacturer), Warwick , QLD. All Vera's Formulations products.

Where next?